212 related articles for article (PubMed ID: 3541490)
1. Blast crisis of chronic myelogenous leukemia. Morphologic and immunological features.
Nemoto K; Honma K; Fukuda T; Ohnishi Y
Acta Pathol Jpn; 1986 Oct; 36(10):1441-54. PubMed ID: 3541490
[TBL] [Abstract][Full Text] [Related]
2. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
Shumak KH; Baker MA; Taub RN; Coleman MS
Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
[TBL] [Abstract][Full Text] [Related]
3. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
Han T; Gomez GA; Minowada J
Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
[TBL] [Abstract][Full Text] [Related]
4. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
5. [T lymphoid blast crisis of Philadelphia chromosome-positive chronic myeloid leukemia: analysis of 3 cases].
Cervantes F; Urbano-Ispizua A; Escoda L; Ordi J; Montserrat E; Rozman C
Med Clin (Barc); 1991 Jun; 97(1):21-3. PubMed ID: 1857142
[TBL] [Abstract][Full Text] [Related]
6. Chronic myelocytic leukemia terminating in blast cell crisis with lymphoblastic characteristics.
Walters TR; Minowada J; Tsubota T; Kataoka K; Han T
Pediatrics; 1978 Nov; 62(5):795-800. PubMed ID: 281667
[TBL] [Abstract][Full Text] [Related]
7. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
Schmetzer HM; Gerhartz HH
Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
9. Cell population analysis of a heterogeneous blast cell crisis of chronic myelogenous leukemia.
Pedraza MA; Mason D; Doslu FA; Marsh RA; Boblett JP
Diagn Immunol; 1984; 2(1):19-24. PubMed ID: 6594209
[TBL] [Abstract][Full Text] [Related]
10. Role of immunophenotyping in characterisation of blast crisis of chronic myeloid leukemia--a study of 25 cases.
Padmanabhan V; Varma N; Dash S; Varma S
Indian J Pathol Microbiol; 1996 Jan; 39(1):13-7. PubMed ID: 8755126
[TBL] [Abstract][Full Text] [Related]
11. [Immunophenotypes on blast cells of chronic myelogenous leukemia].
Motoji T
Nihon Rinsho; 2001 Dec; 59(12):2342-7. PubMed ID: 11766336
[TBL] [Abstract][Full Text] [Related]
12. [Extramedullary blast crisis of mixed precursor T lymphoblastic and myeloblastic features in a patient with chronic myelogenous leukemia successfully treated with low-dose oral etoposide].
Konaka Y; Namiuchi S
Rinsho Ketsueki; 1993 Dec; 34(12):1556-61. PubMed ID: 8295329
[TBL] [Abstract][Full Text] [Related]
13. ["Lymphoid" blastic transformation in chronic myelogenous leukemia. Report of three cases (author's transl)].
Bauters F; Jouet JP; Huart JJ; Jude B; Toussaint B; Goudemand M
Sem Hop; 1982 Jan; 58(1):17-23. PubMed ID: 6275542
[TBL] [Abstract][Full Text] [Related]
14. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
15. Lineage switch and multilineage involvement in two cases of pH chromosome-positive acute leukemia: evidence for a stem cell disease.
Cuneo A; Balboni M; Piva N; Carli MG; Tomasi P; Previati R; Negrini M; Scapoli G; Spanedda R; Castoldi G
Haematologica; 1994; 79(1):76-82. PubMed ID: 15378954
[TBL] [Abstract][Full Text] [Related]
16. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
17. [Ph1 positive myeloblastic crisis followed by Ph1 negative, bcr rearrangement positive T lymphoid crisis in a CML case].
Matsushita K; Arima N; Fukumori J; Daitoku Y; Hidaka S; Ohtsubo H; Tanaka H
Rinsho Ketsueki; 1993 Mar; 34(3):348-54. PubMed ID: 8479087
[TBL] [Abstract][Full Text] [Related]
18. Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.
Colla S; Sammarelli G; Crugnola M; Ascani S; Sabbatini E; Bonomini S; Hojden M; Craviotto L; De Celis I; Morandi F; Caramatti C; Rizzoli V; Giuliani N
Eur J Haematol; 2004 May; 72(5):361-5. PubMed ID: 15059073
[TBL] [Abstract][Full Text] [Related]
19. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
20. [The lymphoid-like cells in blastic transformation of chronic myeloid leukemia].
Lovisetto P; Guarnero A; Bonetto M; Biarese V
Minerva Med; 1980 Mar; 71(8):527-39. PubMed ID: 6987552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]